跳至主要内容
临床试验/JPRN-UMIN000001163
JPRN-UMIN000001163已完成未知

Study of optimal treatment duration with antihistamine in idiopathic urticaria patients - Urticaria Dose optimized trial (SOLIDARITIE)

West Japan Urticaria Therapy Study Group0 个研究点目标入组 93 人开始时间: 2008年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
93

研究概览

简要总结

  1. Less patients (70%) in the treated group suffered from recurrences than in the control group (90%). 2. Urticaria scores of patients in the last week of the study, and a number of patients who were either suffering from symptoms or taking medications in the treated group were lower than those in the control group. 3. No relation was observed between the recurrence rate and time to the treatment, time to be symptom-free from the onset of urticaria, and severity of urticaria before the treatment.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with a history of hypersensitivity to fexofenadine hydrochloride 3. Patients who use medications that interfere with the efficacy evaluation (e.g., other antihistamines, drugs with anti-allergy action, systemic steroids etc.) 4. Others whom the physician judges are not suitable as subjects

研究者

发起方
West Japan Urticaria Therapy Study Group

相似试验